Literature DB >> 28152535

The Blood-Retinal Barrier in the Management of Retinal Disease: EURETINA Award Lecture.

José Cunha-Vaz1.   

Abstract

Retinal diseases are the main causes of blindness in the Western world. Diabetic retinopathy and age-related macular degeneration continue to increase in prevalence and as main causes of vision loss. Intravitreal anti-VEGF and steroid injections have raised new expectations for their successful treatment. These agents act by stabilizing the blood-retinal barrier (BRB). Our group defined the BRB by identifying for the first time the tight junctions that unite retinal endothelial cells and are the basis for the inner BRB, an observation later confirmed in retinal pigment epithelial cells and in brain vessels. A major role of active transport processes was also identified. Today, the BRB is understood to play a fundamental role in retinal function in both health and disease. Retinal edema, an ubiquitous manifestation of retinal disease, is directly associated with breakdown of the BRB and with vision loss. In its most common form (i.e., vasogenic edema), due to breakdown of the BRB, Starling's law of capillary filtration may be used to interpret the mechanisms of fluid accumulation in the retina. The main factors involved in the development of retinal edema are BRB permeability, capillary hydrostatic pressure, tissue hydrostatic pressure, tissue osmotic pressure, and plasma osmotic pressure. In the clinical environment, breakdown of the BRB has been identified by fluorescein angiography and vitreous fluorometry, requiring the intravenous administration of fluorescein. An OCT-based method, OCT-Leakage, recently introduced by our group is capable of noninvasively identifying and quantifying sites of alteration of the BRB by mapping areas of lower-than-normal optical reflectivity, thus reflecting changes in the retinal extracellular fluid. We found good correspondence between the location of increased areas of low optical reflectivity identified by OCT-Leakage and the main sites of leakage on fluorescein angiography. Furthermore, with OCT-Leakage the areas of abnormal fluid accumulation can be identified in specific retinal layers, clearly offering more information than previously obtained with fluorescein angiography. OCT angiography has become available, replacing much of the information yielded by fluorescein angiography in a noninvasive manner. However, OCT angiography cannot visualize the leakage, i.e., the alteration of the BRB. OCT-Leakage is able to identify the locations of increases in extracellular fluid in the different layers of the retina. The complementarity of these 2 methods is of potential great interest for the diagnosis and management of several retinal diseases in which the presence and amount of fluid, as a marker of severity and activity, is paramount to treatment and management decisions in clinical practice.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2017        PMID: 28152535     DOI: 10.1159/000455809

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  23 in total

1.  Increased serum proteins in non-exudative AMD retinas.

Authors:  Hannah Schultz; Ying Song; Bailey H Baumann; Rebecca J Kapphahn; Sandra R Montezuma; Deborah A Ferrington; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2019-05-31       Impact factor: 3.467

2.  Astragalus root extract inhibits retinal cell apoptosis and repairs damaged retinal neovascularization in retinopathy of prematurity.

Authors:  Xiaojun Liu; Bin Wang; Yongfa Sun; Yutao Jia; Zhaoying Xu
Journal:  Cell Cycle       Date:  2019-09-29       Impact factor: 4.534

3.  MTPA_Unet: Multi-Scale Transformer-Position Attention Retinal Vessel Segmentation Network Joint Transformer and CNN.

Authors:  Yun Jiang; Jing Liang; Tongtong Cheng; Xin Lin; Yuan Zhang; Jinkun Dong
Journal:  Sensors (Basel)       Date:  2022-06-17       Impact factor: 3.847

4.  Fibroblast Growth Factor 21 Protects Photoreceptor Function in Type 1 Diabetic Mice.

Authors:  Zhongjie Fu; Zhongxiao Wang; Chi-Hsiu Liu; Yan Gong; Bertan Cakir; Raffael Liegl; Ye Sun; Steven S Meng; Samuel B Burnim; Ivana Arellano; Elizabeth Moran; Rubi Duran; Alexander Poblete; Steve S Cho; Saswata Talukdar; James D Akula; Ann Hellström; Lois E H Smith
Journal:  Diabetes       Date:  2018-02-27       Impact factor: 9.461

5.  Long-Term Functional and Structural Consequences of Primary Blast Overpressure to the Eye.

Authors:  Rachael S Allen; Cara T Motz; Andrew Feola; Kyle C Chesler; Raza Haider; Sriganesh Ramachandra Rao; Lara A Skelton; Steven J Fliesler; Machelle T Pardue
Journal:  J Neurotrauma       Date:  2018-07-02       Impact factor: 5.269

6.  Imaging Features of Vessels and Leakage Patterns Predict Extended Interval Aflibercept Dosing Using Ultra-Widefield Angiography in Retinal Vascular Disease: Findings From the PERMEATE Study.

Authors:  Azam Moosavi; Natalia Figueiredo; Prateek Prasanna; Sunil K Srivastava; Sumit Sharma; Anant Madabhushi; Justis P Ehlers
Journal:  IEEE Trans Biomed Eng       Date:  2021-05-21       Impact factor: 4.756

7.  Epigenetic modifications in hyperhomocysteinemia: potential role in diabetic retinopathy and age-related macular degeneration.

Authors:  Khaled Elmasry; Riyaz Mohamed; Isha Sharma; Nehal M Elsherbiny; Yutao Liu; Mohamed Al-Shabrawey; Amany Tawfik
Journal:  Oncotarget       Date:  2018-01-29

8.  Relationship Between Neutralizing Antibodies Against Adeno-Associated Virus in the Vitreous and Serum: Effects on Retinal Gene Therapy.

Authors:  Suhwan Lee; Im Kyeung Kang; Ji Hyun Kim; Bok Kyoung Jung; Keerang Park; Heesoon Chang; Joo Yong Lee; Heuiran Lee
Journal:  Transl Vis Sci Technol       Date:  2019-04-09       Impact factor: 3.283

9.  Retinal Phenotype in the rd9 Mutant Mouse, a Model of X-Linked RP.

Authors:  Antonio Falasconi; Martina Biagioni; Elena Novelli; Ilaria Piano; Claudia Gargini; Enrica Strettoi
Journal:  Front Neurosci       Date:  2019-09-19       Impact factor: 4.677

10.  N-Methyl-D-aspartate receptor activation, novel mechanism of homocysteine-induced blood-retinal barrier dysfunction.

Authors:  Amany Tawfik; Riyaz Mohamed; Dina Kira; Suhib Alhusban; Mohamed Al-Shabrawey
Journal:  J Mol Med (Berl)       Date:  2020-11-06       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.